Ewa Gurgul-Convey1, Ilir Mehmeti1, Thomas Plötz1, Anne Jörns1, Sigurd Lenzen2,3. 1. Institute of Clinical Biochemistry, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. 2. Institute of Clinical Biochemistry, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. lenzen.sigurd@mh-hannover.de. 3. Institute of Experimental Diabetes Research, Hannover Medical School, Hannover, Germany. lenzen.sigurd@mh-hannover.de.
Abstract
AIMS/HYPOTHESIS: The aim of this study was to perform a detailed analysis of cytokine toxicity in the new human EndoC-βH1 beta cell line. METHODS: The expression profile of the antioxidative enzymes in the new human EndoC-βH1 beta cells was characterised and compared with that of primary beta cells in the human pancreas. The effects of proinflammatory cytokines on reactive oxygen species formation, insulin secretory responsiveness and apoptosis of EndoC-βH1 beta cells were determined. RESULTS: EndoC-βH1 beta cells were sensitive to the toxic action of proinflammatory cytokines. Glucose-dependent stimulation of insulin secretion and an increase in the ATP/ADP ratio was abolished by proinflammatory cytokines without induction of IL-1β expression. Cytokine-mediated caspase-3 activation was accompanied by reactive oxygen species formation and developed more slowly than in rodent beta cells. Cytokines transiently increased the expression of unfolded protein response genes, without inducing endoplasmic reticulum stress-marker genes. Cytokine-mediated NFκB activation was too weak to induce inducible nitric oxide synthase expression. The resultant lack of nitric oxide generation in EndoC-βH1 cells, in contrast to rodent beta cells, makes these cells dependent on exogenously generated nitric oxide, which is released from infiltrating immune cells in human type 1 diabetes, for full expression of proinflammatory cytokine toxicity. CONCLUSIONS/ INTERPRETATION: EndoC-βH1 beta cells are characterised by an imbalance between H2O2-generating and -inactivating enzymes, and react to cytokine exposure in a similar manner to primary human beta cells. They are a suitable beta cell surrogate for cytokine-toxicity studies.
AIMS/HYPOTHESIS: The aim of this study was to perform a detailed analysis of cytokine toxicity in the new human EndoC-βH1 beta cell line. METHODS: The expression profile of the antioxidative enzymes in the new human EndoC-βH1 beta cells was characterised and compared with that of primary beta cells in the human pancreas. The effects of proinflammatory cytokines on reactive oxygen species formation, insulin secretory responsiveness and apoptosis of EndoC-βH1 beta cells were determined. RESULTS: EndoC-βH1 beta cells were sensitive to the toxic action of proinflammatory cytokines. Glucose-dependent stimulation of insulin secretion and an increase in the ATP/ADP ratio was abolished by proinflammatory cytokines without induction of IL-1β expression. Cytokine-mediated caspase-3 activation was accompanied by reactive oxygen species formation and developed more slowly than in rodent beta cells. Cytokines transiently increased the expression of unfolded protein response genes, without inducing endoplasmic reticulum stress-marker genes. Cytokine-mediated NFκB activation was too weak to induce inducible nitric oxide synthase expression. The resultant lack of nitric oxide generation in EndoC-βH1 cells, in contrast to rodent beta cells, makes these cells dependent on exogenously generated nitric oxide, which is released from infiltrating immune cells in human type 1 diabetes, for full expression of proinflammatory cytokine toxicity. CONCLUSIONS/ INTERPRETATION: EndoC-βH1 beta cells are characterised by an imbalance between H2O2-generating and -inactivating enzymes, and react to cytokine exposure in a similar manner to primary human beta cells. They are a suitable beta cell surrogate for cytokine-toxicity studies.
Authors: D L Eizirik; S Sandler; N Welsh; M Cetkovic-Cvrlje; A Nieman; D A Geller; D G Pipeleers; K Bendtzen; C Hellerström Journal: J Clin Invest Date: 1994-05 Impact factor: 14.808
Authors: J Nerup; T Mandrup-Poulsen; S Helqvist; H U Andersen; F Pociot; J I Reimers; B G Cuartero; A E Karlsen; U Bjerre; T Lorenzen Journal: Diabetologia Date: 1994-09 Impact factor: 10.122
Authors: Ernesto S Nakayasu; Farooq Syed; Sarah A Tersey; Marina A Gritsenko; Hugh D Mitchell; Chi Yuet Chan; Ercument Dirice; Jean-Valery Turatsinze; Yi Cui; Rohit N Kulkarni; Decio L Eizirik; Wei-Jun Qian; Bobbie-Jo M Webb-Robertson; Carmella Evans-Molina; Raghavendra G Mirmira; Thomas O Metz Journal: Cell Metab Date: 2020-01-09 Impact factor: 27.287
Authors: T Plötz; B Krümmel; A Laporte; A Pingitore; S J Persaud; A Jörns; M Elsner; I Mehmeti; S Lenzen Journal: Nutr Diabetes Date: 2017-12-21 Impact factor: 5.097
Authors: Benoît Hastoy; Mahdieh Godazgar; Anne Clark; Vibe Nylander; Ioannis Spiliotis; Martijn van de Bunt; Margarita V Chibalina; Amy Barrett; Carla Burrows; Andrei I Tarasov; Raphael Scharfmann; Anna L Gloyn; Patrik Rorsman Journal: Sci Rep Date: 2018-11-19 Impact factor: 4.379
Authors: Kaiyven A Leslie; Mark A Russell; Kazuto Taniguchi; Sarah J Richardson; Noel G Morgan Journal: Diabetologia Date: 2018-10-18 Impact factor: 10.122